Disc Medicine (NASDAQ:IRON) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Disc Medicine (NASDAQ:IRON – Free Report) in a research note published on Friday morning, Benzinga reports. Cantor Fitzgerald currently has a $85.00 target price on the stock. Several other analysts have also recently issued reports on the stock. Wedbush reissued an outperform rating and set a […]

Leave a Reply

Your email address will not be published.

Previous post Kemper Co. (NYSE:KMPR) Given Consensus Recommendation of “Buy” by Analysts
Next post MEI Pharma (NASDAQ:MEIP) Now Covered by StockNews.com